The new guideline limiting CT testing might lead to a more than twofold reduction in diagnoses and antibiotic prescriptions in women and heterosexual men. Surveillance of STIs and associated complicat...

Despite their established effectiveness, uptake of the WHO best buys for tackling non-communicable diseases (NCDs) has been uneven and disappointing. Here we introduce the “quick buys”, an evidence-ba...

In July and August 2025, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the granting of an EU-wide authorisation for eight new medicines (...

Before a high-risk medical device is approved for implantation into patients, there should be evidence not only of its performance and safety with a favourable benefit-risk ratio, but also of its clin...

Despite improvements from 2003 to 2022, persistent disparities underscore ongoing inequities and the need for targeted efforts to promote equity.

Since 1990, life expectancy has increased in Poland for both males and females, with males gaining more years of expected life. In 2023 it was higher than in eastern and central Europe but behind west...

The risk of a first ICH/FND from CCM is low, while the risk of recurrence is significantly higher, although the recurrence risk declines dramatically five years after a first ICH/FND. These long-term findings can guide clinical decision-making, and suggest focussing on a 5-year risk horizon rather than extrapolating annual risks to patients' lifetimes.

Despite well-established health-care systems in many high-income and middle-income regions, persistent gaps in representation, access, and care continue to undermine equity in cardiovascular health, r...

Despite well-established health-care systems in many high-income and middle-income regions, persistent gaps in representation, access, and care continue to undermine equity in cardiovascular health, r...

Cardiovascular disease is responsible for more than 40% of all deaths in Europe. Decades of research and investment have achieved impressive declines in overall cardiovascular disease mortality, yet t...

We have found changes in access to care, with a shift towards testing via OPSS, and variations in who tests where and differences in positivity by testing mode and gender. Further research is needed t...

Position: Senior Editor, The Lancet Regional Health – Europe Location: Barcelona or Berlin or Munich or London Do you enjoy using science to drive change in the world? Are you passionate about improvi...

Rotigotine administration may not be a viable therapeutic option for enhancing frontal function, slowing disease progression, mitigating functional decline or ameliorating behavioral disturbances in b...

Podcast Episode · The Lancet Regional Health Europe in conversation with · 08/01/2025 · 16m

The 2025 International Refugee and Migration Health Conference (IRMHC) convened 614 health professionals, scholars, students, advocates, artists, and community leaders in Halifax, Nova Scotia, Canada—...